Urotronic has raised $20 million in an equity offering involving 7 investors, according to a document filed with the SEC this week.
The Minnesota-based company is developing a drug-coated balloon catheter designed to treat urethral strictures in men. Urotronic’s latest fundraising efforts come on the heels of a $6 million offering that closed in July.
Get the full story at our sister site, Drug Delivery Business News.
The post Urotronic raises $20m for drug-coated balloon catheter appeared first on MassDevice.